The US Hemp Authority announced that they are starting the country’s first Adult Hemp Product certification program.
In a recent press release (1), the US Hemp Authority (USHA) revealed their new adult use certificate program for delta-9-tetrahydrocannabinol (THC) and delta-8-THC. Currently the USHA has a five-year program targeted for non-intoxicating hemp and cannabidiol (CBD) products. The US government has not instated federal regulations on the hemp or cannabis industry so there is no uniformed quality control measures established to provide guidance. The adult certification program is set to educate policymakers and consumers to help them to “distinguish between quality manufacturers and the bad actors in the industry,” (1).
“With great pride, today we launch the Adult Use Certification Program. Hemp products intended for adults have become prevalent, and with a lack of federal oversight, companies now have the opportunity to self-regulate, attain certification, and demonstrate to their customers, their points of distribution, and their competitors that they are acting in good faith and making quality products. We intend to ensure the hemp industry regulates itself to increase safety and stability, and to demonstrate to legislators and regulators that the industry is made primarily of good actors trying to bring quality products to consumers,” Chris Fontes, president of the USHA, discussed about the new program (1).
The USHA has hired Ceres Certifications International (CCI) as a third-party auditor to “ensure the integrity of the program” (1). CCI conducts global food safety initiative (GFSI) level audits, as well as non-GFSI inspection audits which include the USHA, PrimusStandard, International Fresh Produce Harmonized Audit, and more.
Back in April 2024, Nutritional Outlook, reported on the USHA’s Adult Use Hemp Product Certification Program (2) “which was designed for hemp derived extracts such as delta-8 and delta-9 THC, which have the potential to impair users.” The USHA wants to instill “additional compliance points” to help encourage safety for the public.
To learn more and sign up for the certification seal, click here.
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
2 Commerce Drive
Cranbury, NJ 08512